Rhovac hires investment bank to generate interest in lead candidate

Biotech company Rhovac is on the lookout for a deal or a partnership regarding its lead candidate. International investment managing firm Stifel Nicolaus Europe has been appointed to help with the task.
Photo: Jens Dresling
Photo: Jens Dresling

Danish biotech company Rhovac, spearheaded by Anders Månsson, former executive of  Leo Pharma and Ferring Pharmaceuticals, has made it its goal to examine the opportunities of either striking a deal or entering a partnership pertaining to its lead candidate RV001, the company reports in a press relase on Monday.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
Must be at least 8 characters, including three of: Uppercase, lowercase, numbers, symbols
Must contain at least 2 characters
Must contain at least 2 characters

Get full access for you and your coworkers

Start a free company trial today

Share article

Sign up for our newsletter

Stay ahead of development by receiving our newsletter on the latest sector knowledge.

Newsletter terms

Front page now

Further reading